In financial year 2022, the cost of healthcare goods and services, also known as medical inflation, reached approximately **** percent in India. This figure was significantly higher than the general inflation rate in the country. In fiscal year 2023, medical inflation is forecasted to decrease to **** percent.

India Consumer Price Index (CPI): Miscellaneous: Health data was reported at 200.500 2012=100 in Mar 2025. This records an increase from the previous number of 199.600 2012=100 for Feb 2025. India Consumer Price Index (CPI): Miscellaneous: Health data is updated monthly, averaging 133.800 2012=100 from Jan 2011 (Median) to Mar 2025, with 171 observations. The data reached an all-time high of 200.500 2012=100 in Mar 2025 and a record low of 89.500 2012=100 in Jan 2011. India Consumer Price Index (CPI): Miscellaneous: Health data remains active status in CEIC and is reported by Ministry of Statistics and Programme Implementation. The data is categorized under Global Database’s India – Table IN.HD002: Consumer Price Index.

This dataset provides the latest health Inflation rate of India, as published by the Ministry of Statistics & Programme Implementation, along with historical trends.

In December 2024, the Consumer Price Index for health across India was *** which indicates that it had increased by approximately ** percent since the considered base year 2012. The index for the same category in rural India was *** that month, while CPI of health of urban India was *****. The Consumer Price Index measures the average change in prices over time that consumers pay for a basket of goods and services.

For 2022, the forecasted gross medical cost trend in the Asia-Pacific region was highest in India, reaching approximately **** percent. This was followed by Malaysia, where the forecasted gross medical cost trend amounted to around **** percent. Comparatively, the forecasted gross medical cost trend in South Korea was estimated to amount to about *** percent in that year.

High Frequency Indicator: The dataset contains year-, month- and item-wise compiled data from the year 2015 to till date on inflation rates of different singular and combined items. These include food items such as rice, chicken, suwai, bajra, meat, vegetables, and others things, clothing items such as dhoti, saree, shawl, shirts, pants, fuels such as petrol, diesel, kerosene, LPG, coal, amenities such as air coolers, air conditioners. washing machines, bathroom and sanitary items, furniture, washing machine, and other items such as medical, motor, transport, telecommunication, electronic and other items

The Consumer Price Index in India increased 0.15 percent in October of 2025 over the previous month. This dataset provides - India Inflation Rate MoM- actual values, historical data, forecast, chart, statistics, economic calendar and news.

The Consumer Price Index (CPI) is a measure that examines the weighted average of prices of a basket of consumer goods and services, such as transportation, food, and medical care. It is calculated by taking price changes for each item in the predetermined basket and averaging them. Prices are collected periodically, and the CPI is often used to measure inflation, reflecting the cost of living. The CPI is typically set against a base year. The index is set to 100 in the base year, and changes in the CPI indicate price changes compared to that year. A typical household might purchase a wide range of products and services. Items in the basket are weighted according to their importance or share in total household spending. The Inflation Rate is the percentage increase in the general level of prices for goods and services over a period of time. It indicates how much prices have risen over a specific period, typically a year. Higher inflation decreases the purchasing power of money, meaning consumers can buy less with the same amount of money.It reflects the overall health of an economy. Moderate inflation is expected in a growing economy, but hyperinflation can indicate economic instability. The Inflation Rate is calculated using the following formula: Inflation Rate (%) = ((CPI in Current Year−CPI in Previous Year)/ (CPI in Previous Year))×100

• The global industry was valued at US$ 537.7 Mn in 2022
• It is projected to grow at a CAGR of 5.2% from 2023 to 2031 and reach more than US$ 851.8 Mn by the end of 2031

Global Inflation Devices Market Snapshot

Attribute	Detail
Market Value in 2022	US$ 537.7 Mn
Forecast (Value) in 2031	US$ 851.8 Mn
Growth Rate (CAGR)	5.2%
Forecast Period	2023-2031
Historical Data Available for	2017-2021
Quantitative Units	US$ Mn for Value
Market Analysis	It provides segment analysis as well as regional level analysis. Furthermore, qualitative analysis includes drivers, restraints, opportunities, key trends, Porter’s Five Forces analysis, value chain analysis, and key trend analysis.
Competition Landscape	Market share analysis by company (2022) Company profiles section includes overview, product portfolio, sales footprint, key subsidiaries or distributors, strategy & recent developments, and key financials
Format	Electronic (PDF) + Excel
Market Segmentation	Display Type Analog Inflation Devices Digital Inflation Devices Pressure Capacity 20 ml Inflation Devices 30 ml Inflation Devices 60 ml Inflation Devices Function Balloon Angioplasty Arterial Stent Placement Endoscopy Others Application Coronary Interventions Urology Gastroenterology Peripheral Interventions Others End-user Hospitals Specialty Clinics Ambulatory Surgery Centers
Regions Covered	North America Latin America Europe Asia Pacific Middle East & Africa
Countries Covered	U.S. Canada Germany U.K. France Italy Spain China India Japan Australia & New Zealand Brazil Mexico South Africa GCC Countries
Companies Profiled	Atrion Medical BD Lepu Medical Technology (Beijing) Co., Ltd. Merit Medical Systems Translumina Advin Health Care Dolphin Life Science India LLP Boston Scientific Corporation Acclarent, Inc. (Johnson & Johnson MedTech) B. Braun Interventional Systems Inc. CONMED Corporation Cook Medical
Customization Scope	Available upon request
Pricing	Available upon request

India Consumer Price Index (CPI): Miscellaneous: Other Medical Expenses Non-Institutional data was reported at 127.900 2012=100 in Oct 2018. This records an increase from the previous number of 120.100 2012=100 for Sep 2018. India Consumer Price Index (CPI): Miscellaneous: Other Medical Expenses Non-Institutional data is updated monthly, averaging 117.150 2012=100 from Jan 2014 (Median) to Oct 2018, with 58 observations. The data reached an all-time high of 127.900 2012=100 in Oct 2018 and a record low of 107.700 2012=100 in Jan 2014. India Consumer Price Index (CPI): Miscellaneous: Other Medical Expenses Non-Institutional data remains active status in CEIC and is reported by Central Statistics Office. The data is categorized under India Premium Database’s Inflation – Table IN.IA017: Consumer Price Index: 2012=100: Miscellaneous.

India Retail Price Index: Industrial Workers: 2001p: Weights: Medical Care: Medicine: Allopathic data was reported at 2.680 % in Oct 2018. This stayed constant from the previous number of 2.680 % for Sep 2018. India Retail Price Index: Industrial Workers: 2001p: Weights: Medical Care: Medicine: Allopathic data is updated monthly, averaging 2.680 % from Jan 2006 (Median) to Oct 2018, with 154 observations. The data reached an all-time high of 2.680 % in Oct 2018 and a record low of 2.680 % in Oct 2018. India Retail Price Index: Industrial Workers: 2001p: Weights: Medical Care: Medicine: Allopathic data remains active status in CEIC and is reported by Labour Bureau Government of India. The data is categorized under India Premium Database’s Inflation – Table IN.IG028: Retail Price Index: Industrial Workers: 2001=100: Weights: Miscellaneous: Medical Care.

India Retail Price Index: Industrial Workers: 2001p: Weights: Medical Care: Doctors' Fee data was reported at 0.750 % in Oct 2018. This stayed constant from the previous number of 0.750 % for Sep 2018. India Retail Price Index: Industrial Workers: 2001p: Weights: Medical Care: Doctors' Fee data is updated monthly, averaging 0.750 % from Jan 2006 (Median) to Oct 2018, with 154 observations. The data reached an all-time high of 0.750 % in Oct 2018 and a record low of 0.750 % in Oct 2018. India Retail Price Index: Industrial Workers: 2001p: Weights: Medical Care: Doctors' Fee data remains active status in CEIC and is reported by Labour Bureau Government of India. The data is categorized under India Premium Database’s Inflation – Table IN.IG028: Retail Price Index: Industrial Workers: 2001=100: Weights: Miscellaneous: Medical Care.

The global market for inflation devices is experiencing steady growth, projected to reach $530.6 million in 2025 and exhibiting a Compound Annual Growth Rate (CAGR) of 3.9% from 2025 to 2033. This growth is fueled by several key factors. The increasing prevalence of cardiovascular diseases and the rising demand for minimally invasive procedures are primary drivers. Technological advancements leading to the development of more sophisticated and effective inflation devices, along with improved patient outcomes, are also contributing significantly. The market is segmented by application (hospitals, clinics, and others) and by device type (20 mL, 30 mL, and 60 mL), reflecting the diverse needs of healthcare providers and patients. Hospitals currently dominate the application segment due to their extensive infrastructure and specialized personnel. However, the clinics segment is expected to witness robust growth due to increasing preference for outpatient procedures and rising investments in ambulatory care facilities. The demand for smaller device sizes (20 mL and 30 mL) is likely higher due to their suitability for various procedures and minimal invasiveness. The geographical distribution reveals strong market presence in North America and Europe, driven by advanced healthcare infrastructure and high healthcare expenditure. However, emerging economies in Asia-Pacific, particularly India and China, are anticipated to experience faster growth rates due to expanding healthcare access and rising disposable incomes. Competition is intense, with major players like Medtronic, Boston Scientific, and Abbott Laboratories dominating the market through innovative product offerings and strong distribution networks. Despite the positive outlook, the market faces certain restraints. High costs associated with inflation devices, coupled with stringent regulatory approvals and reimbursement challenges, could potentially limit market expansion. The increasing focus on cost-effectiveness and the need for more affordable alternatives are likely to shape future market dynamics. Furthermore, the adoption of alternative treatment modalities could also pose a challenge to the growth of the inflation device market. However, continued research and development efforts focused on improving device efficacy and safety, coupled with strategic collaborations among stakeholders, are expected to mitigate these challenges and sustain the market's growth trajectory throughout the forecast period.

India Retail Price Index: Industrial Workers: 2001p: Weights: Medical Care: X-ray Charges data was reported at 0.060 % in Oct 2018. This stayed constant from the previous number of 0.060 % for Sep 2018. India Retail Price Index: Industrial Workers: 2001p: Weights: Medical Care: X-ray Charges data is updated monthly, averaging 0.060 % from Jan 2006 (Median) to Oct 2018, with 154 observations. The data reached an all-time high of 0.060 % in Oct 2018 and a record low of 0.060 % in Oct 2018. India Retail Price Index: Industrial Workers: 2001p: Weights: Medical Care: X-ray Charges data remains active status in CEIC and is reported by Labour Bureau Government of India. The data is categorized under India Premium Database’s Inflation – Table IN.IG028: Retail Price Index: Industrial Workers: 2001=100: Weights: Miscellaneous: Medical Care.

India Retail Price Index: Industrial Workers: 2001p: Medical Care: Doctors' Fee data was reported at 393.040 2001=100 in Oct 2018. This records an increase from the previous number of 390.600 2001=100 for Sep 2018. India Retail Price Index: Industrial Workers: 2001p: Medical Care: Doctors' Fee data is updated monthly, averaging 210.845 2001=100 from Jan 2006 (Median) to Oct 2018, with 154 observations. The data reached an all-time high of 393.040 2001=100 in Oct 2018 and a record low of 117.020 2001=100 in Jan 2006. India Retail Price Index: Industrial Workers: 2001p: Medical Care: Doctors' Fee data remains active status in CEIC and is reported by Labour Bureau Government of India. The data is categorized under India Premium Database’s Inflation – Table IN.IG012: Retail Price Index: Industrial Workers: 2001=100: Miscellaneous: Medical Care.

Prescription Price Transparency Tools Market Outlook

According to our latest research, the Global Prescription Price Transparency Tools market size was valued at $1.7 billion in 2024 and is projected to reach $6.5 billion by 2033, expanding at a CAGR of 15.8% during 2024–2033. The major factor propelling the growth of this market globally is the increasing demand from patients, healthcare providers, and payers for real-time access to accurate prescription pricing data. This demand is further fueled by rising healthcare costs, complex insurance structures, and a growing emphasis on patient empowerment and cost containment in healthcare delivery. As stakeholders seek to make more informed decisions and mitigate out-of-pocket expenses, prescription price transparency tools are becoming integral to the healthcare ecosystem, driving adoption and market expansion worldwide.

Regional Outlook

North America holds the largest share of the global Prescription Price Transparency Tools market, accounting for approximately 45% of total revenue in 2024. This dominance is underpinned by a mature healthcare infrastructure, widespread adoption of digital health technologies, and proactive policy initiatives aimed at promoting price transparency. The United States, in particular, has witnessed a surge in regulatory mandates requiring pharmacies and insurers to disclose drug pricing information, which has accelerated the deployment of price transparency solutions. High healthcare expenditure, the presence of leading technology vendors, and a robust payer-provider ecosystem have further fueled market growth in this region. In addition, North American consumers are increasingly demanding transparency and control over their healthcare spending, making the region a fertile ground for innovative pricing tools and services.

The Asia Pacific region is emerging as the fastest-growing market, projected to register a CAGR of over 19% during the forecast period. This rapid expansion is driven by escalating investments in healthcare IT infrastructure, rising awareness among patients, and government initiatives to curb drug price inflation. Countries such as China, India, and Japan are witnessing increased adoption of cloud-based healthcare solutions, which facilitate seamless integration and scalability of price transparency tools. Moreover, the burgeoning middle-class population and expanding insurance coverage are creating new opportunities for service providers. The influx of international players and local startups, coupled with strategic partnerships between technology firms and healthcare organizations, is further propelling market growth across the Asia Pacific landscape.

In emerging economies across Latin America, the Middle East, and Africa, the adoption of prescription price transparency tools remains nascent but is gradually gaining momentum. These regions face unique challenges, including fragmented healthcare delivery systems, limited digital infrastructure, and varying regulatory environments. However, localized demand is increasing as governments and private sector stakeholders recognize the potential of price transparency to enhance affordability and accessibility of medicines. Policy reforms aimed at improving healthcare efficiency and reducing out-of-pocket expenses are beginning to take shape, though the pace of implementation varies significantly between countries. Overcoming barriers such as low digital literacy, data privacy concerns, and resource constraints will be critical for broader market penetration in these regions.

Report Scope

Attributes	Details
Report Title	Prescription Price Transparency Tools Market Research Report 2033
By Component	Software, Services
By Deployment Mode	Cloud-based, On-premises
By Application	Hospitals, Pharmacies, Insurance Providers, Patients, Others
By End-User <

Filipinos spent about ****** Philippine pesos on health in 2024, indicating growth from the previous year. The National Capital Region had the highest health expenditures in that year. Rising current health expenditures The country’s health spending has been steadily rising in the past few years, reaching its peak value in 2024. Increased healthcare spending was particularly noted between 2020 and 2021 when the COVID-19 pandemic hit, as Filipinos purchased more essential health products and medicines to better protect themselves from the virus. Factors contributing to increased health spending In addition to the coronavirus pandemic, high inflation rates in the Philippines between 2022 and 2023, fueled the increasing prices of medicines and other pharmaceutical goods. To lower the prices of medicines, the government has been encouraging foreign pharmaceutical firms to establish facilities in the country to increase local production. Discussions were being held between pharmaceutical firms such as in India, which was the leading source of pharmaceutical imports to the Philippines.

India Retail Price Index: Industrial Workers: 2001p: Medical Care: Medicine: Homeopathic data was reported at 265.790 2001=100 in Oct 2018. This records an increase from the previous number of 264.860 2001=100 for Sep 2018. India Retail Price Index: Industrial Workers: 2001p: Medical Care: Medicine: Homeopathic data is updated monthly, averaging 188.425 2001=100 from Jan 2006 (Median) to Oct 2018, with 154 observations. The data reached an all-time high of 265.790 2001=100 in Oct 2018 and a record low of 123.910 2001=100 in Jan 2006. India Retail Price Index: Industrial Workers: 2001p: Medical Care: Medicine: Homeopathic data remains active status in CEIC and is reported by Labour Bureau Government of India. The data is categorized under India Premium Database’s Inflation – Table IN.IG012: Retail Price Index: Industrial Workers: 2001=100: Miscellaneous: Medical Care.

Consumer Price Index (CPI): 2001p: Industrial Workers: India: Miscellaneous: Medical Care data was reported at 245.000 2001=100 in Oct 2018. This records an increase from the previous number of 244.000 2001=100 for Sep 2018. Consumer Price Index (CPI): 2001p: Industrial Workers: India: Miscellaneous: Medical Care data is updated monthly, averaging 177.500 2001=100 from Jan 2006 (Median) to Oct 2018, with 154 observations. The data reached an all-time high of 245.000 2001=100 in Oct 2018 and a record low of 122.000 2001=100 in Feb 2006. Consumer Price Index (CPI): 2001p: Industrial Workers: India: Miscellaneous: Medical Care data remains active status in CEIC and is reported by Labour Bureau Government of India. The data is categorized under India Premium Database’s Inflation – Table IN.IE001: Consumer Price Index: Industrial Workers: India.

India Retail Price Index: Industrial Workers: 2001p: Weights: Medical Care: Ultrasound Charges data was reported at 0.010 % in Oct 2018. This stayed constant from the previous number of 0.010 % for Sep 2018. India Retail Price Index: Industrial Workers: 2001p: Weights: Medical Care: Ultrasound Charges data is updated monthly, averaging 0.010 % from Jan 2006 (Median) to Oct 2018, with 154 observations. The data reached an all-time high of 0.010 % in Oct 2018 and a record low of 0.010 % in Oct 2018. India Retail Price Index: Industrial Workers: 2001p: Weights: Medical Care: Ultrasound Charges data remains active status in CEIC and is reported by Labour Bureau Government of India. The data is categorized under India Premium Database’s Inflation – Table IN.IG028: Retail Price Index: Industrial Workers: 2001=100: Weights: Miscellaneous: Medical Care.